Opthea Limited (OPT)
Stock Price:
$13.15 USD
0.85 (6.91%)
Updated Oct 19, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
442.43M |
| Revenue (ttm) |
61,405 |
| Net Income (ttm) |
-11.62M |
| Shares Out |
43.14M |
| EPS (ttm) |
-0.27 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 19, 2020 |
| Last Price |
$13.15 |
| Previous Close |
$12.30 |
| Change ($) |
0.85 |
| Change (%) |
6.91% |
| Day's Open |
13.24 |
| Day's Range |
12.61 - 13.30 |
| Day's Volume |
350,318 |
| 52-Week Range |
10.22 - 21.36 |
More Stats
| Market Cap |
442.43M |
| Enterprise Value |
400.00M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
43.14M |
| Float |
n/a |
| EPS (basic) |
n/a |
| EPS (diluted) |
-0.27 |
| FCF / Share |
-0.14 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
7,205.09 |
| PB Ratio |
6.83 |
| Revenue |
61,405 |
| Operating Income |
-17.55M |
| Net Income |
-11.62M |
| Free Cash Flow |
-6.06M |
| Net Cash |
42.43M |
| Net Cash / Share |
1.26 |
| Gross Margin |
97.80% |
| Operating Margin |
-28,578.63% |
| Profit Margin |
-18,982.80% |
| FCF Margin |
-9,871.72% |
| ROA |
n/a |
| ROE |
n/a |
| ROIC |
-383.00% |
Key stats in USD, based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Performance
Financial numbers in millions AUD.
Financial Overview
| Year | 2020 | 2019 |
|---|
| Revenue | 0.09 | 0.16 |
| Revenue Growth | -45.26% | - |
| Gross Profit | 0.09 | 0.16 |
| Operating Income | -25.45 | -36.75 |
| Net Income | -16.53 | -20.91 |
| Shares Outstanding | 344 | - |
| Earnings Per Share | -50.72 | -71.84 |
| Operating Cash Flow | -8.78 | -24.19 |
| Capital Expenditures | -0.01 | -0.02 |
| Free Cash Flow | -8.79 | -24.20 |
| Cash & Equivalents | 62.02 | 21.53 |
| Total Debt | 0.50 | 0.03 |
| Net Cash / Debt | 61.52 | 21.51 |
| Assets | 71.89 | 37.66 |
| Liabilities | 7.08 | 6.54 |
| Book Value | 64.81 | 31.12 |
Numbers in millions AUD, except per-share numbers.
Company Details
| Full Name |
Opthea Limited |
| Country |
Australia |
| Employees |
8 |
| CEO |
Megan Baldwin |
Stock Information
| Ticker Symbol |
OPT |
| Stock Exchange |
NASDAQ |
| Sector |
Health Technology |
| Industry |
Pharmaceuticals: Other |
| Unique Identifier |
NASDAQ: OPT |
| IPO Date |
October 16, 2020 |
Description
Opthea is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It targets to treat neovascular age-related macular degeneration (wet AMD) and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984 and is headquartered in South Yarra, Australia.